Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NRSN Neuro Sense Therapeutics Ltd.	$12.1M	$0 0.0% of portfolio	0	Q3 2024 New
NXTC Next Cure, Inc.	$22.2M	$0 0.0% of portfolio	0	Q3 2024 New
NKTX Nkarta, Inc.	$114M	$0 0.0% of portfolio	0	Q3 2024 New
NVAX Novavax Inc	$729M	$0 0.0% of portfolio	0	Q3 2024 New
NRXPW Nrx Pharmaceuticals Inc Wt Exp	$0	$0 0.0% of portfolio	0	Q3 2024 New
NRIX Nurix Therapeutics, Inc.	$860M	$0 0.0% of portfolio	0	Q3 2024 New
NTRB Nutri Band Inc.	$34.2M	$0 0.0% of portfolio	0	Q3 2024 New
NUVL Nuvalent, Inc.	$3.29B	$0 0.0% of portfolio	0	Q3 2024 New
NUVB Nuvation Bio Inc.	$604M	$0 0.0% of portfolio	0	Q3 2024 New
NVCT Nuvectis Pharma, Inc.	$85.1M	$0 0.0% of portfolio	0	Q3 2024 New
OBSV Obs Eva Sa	$0	$0 0.0% of portfolio	0	Q3 2024 New
OCGN Ocugen, Inc.	$171M	$0 0.0% of portfolio	0	Q3 2024 New
OCUL Ocular Therapeutix, Inc	$632M	$0 0.0% of portfolio	0	Q3 2024 New
OCUP Ocuphire Pharma, Inc.	$20.2M	$0 0.0% of portfolio	0	Q3 2024 Sold Out
OLMA Olema Pharmaceuticals, Inc.	$204M	$0 0.0% of portfolio	0	Q3 2024 New
OMGA Omega Therapeutics, Inc.	$34M	$0 0.0% of portfolio	0	Q3 2024 New
OMER Omeros Corp	$555M	$0 0.0% of portfolio	0	Q3 2024 New
ONCY Oncolytics Biotech Inc	$49.2M	$0 0.0% of portfolio	0	Q3 2024 New
OPNT Opiant Pharmaceuticals, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
OGEN Oragenics Inc	$37.2M	$0 0.0% of portfolio	0	Q3 2024 New
ORTX Orchard Therapeutics PLC	$0	$0 0.0% of portfolio	0	Q3 2024 New
ONVO Organovo Holdings, Inc.	$3.57M	$0 0.0% of portfolio	0	Q3 2024 New
ORIC Oric Pharmaceuticals, Inc.	$315M	$0 0.0% of portfolio	0	Q3 2024 New
OVID Ovid Therapeutics Inc.	$57.7M	$0 0.0% of portfolio	0	Q3 2024 New
OYST Oyster Point Pharma, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
PBLA Panbela Therapeutics, Inc.	$7.48M	$0 0.0% of portfolio	0	Q3 2024 New
KTTAW Pasithea Therapeutics Corp Wt	$0	$0 0.0% of portfolio	0	Q3 2024 New
PASG Passage Bio, Inc.	$36.5M	$0 0.0% of portfolio	0	Q3 2024 New
PDSB Pds Biotechnology Corp	$40.1M	$0 0.0% of portfolio	0	Q3 2024 New
PEPG Pep Gen Inc.	$70.2M	$0 0.0% of portfolio	0	Q3 2024 New
PMCB Pharma Cyte Biotech, Inc.	$32.8M	$0 0.0% of portfolio	0	Q3 2024 New
PHAR Pharming Group N.V.	$633M	$0 0.0% of portfolio	0	Q3 2024 New
PHVS Pharvaris N.V.	$601M	$0 0.0% of portfolio	0	Q3 2024 New
PHAT Phathom Pharmaceuticals, Inc.	$272M	$0 0.0% of portfolio	0	Q3 2024 New
PHIO Phio Pharmaceuticals Corp.	$22.5M	$0 0.0% of portfolio	0	Q3 2024 New
PLRX Pliant Therapeutics, Inc.	$585M	$0 0.0% of portfolio	0	Q3 2024 New
PMVP Pmv Pharmaceuticals, Inc.	$66.6M	$0 0.0% of portfolio	0	Q3 2024 New
PSTX Poseida Therapeutics, Inc.	$815M	$0 0.0% of portfolio	0	Q3 2024 New
PGEN Precigen, Inc.	$246M	$0 0.0% of portfolio	0	Q3 2024 New
PRLD Prelude Therapeutics Inc	$38.6M	$0 0.0% of portfolio	0	Q3 2024 New
PROK Prokidney Corp Ord Shs Cl A(Cy	$99.7M	$0 0.0% of portfolio	0	Q3 2024 New
PRQR Pro Qr Therapeutics N.V.	$183M	$0 0.0% of portfolio	0	Q3 2024 New
PTIX Protagenic Therapeutics, Inc.New	$8.26M	$0 0.0% of portfolio	0	Q3 2024 New
PTGX Protagonist Therapeutics, Inc	$1.8B	$0 0.0% of portfolio	0	Q3 2024 New
PLX Protalix Bio Therapeutics, Inc.	$109M	$0 0.0% of portfolio	0	Q3 2024 New
TARA Protara Therapeutics, Inc.	$65.5M	$0 0.0% of portfolio	0	Q3 2024 New
PRTA Prothena Corp Public LTD CO	$612M	$0 0.0% of portfolio	0	Q3 2024 New
PTCT Ptc Therapeutics, Inc.	$3.14B	$0 0.0% of portfolio	0	Q3 2024 New
PBYI Puma Biotechnology, Inc.	$151M	$0 0.0% of portfolio	0	Q3 2024 New
PRTC Pure Tech Health PLC	$491M	$0 0.0% of portfolio	0	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.